{"id":{"repo_id":"wfu","oai_identifier":"oai:wakespace.lib.wfu.edu:10339/57421"},"canonical_url":"https://search.dev.ndltd.org/etd/wfu/oai:wakespace.lib.wfu.edu:10339/57421","repository":{"repo_id":"wfu","name":"Wake Forest University","base_url":"https://wakespace.lib.wfu.edu/oai/request"},"display":{"title":"INTERDEPENDENT REGULATION OF METABOLISM AND INFLAMMATION IN HUMAN MONOCYTES","abstract":"Sepsis is serious medical condition which kills millions of people worldwide each year. In the United States, severe sepsis has a mortality rate of 20-30%, with an annual cost of over $25 billion. Modern advances in supportive care have brought the mortality rate down to its current level, however there is currently no molecular-based treatment available for sepsis. Many treatments have been tested in clinical trials, but none have proven reliably beneficial. These treatments, however, seldom accounted for the fact sepsis has distinct stages with distinct immunometabolic profiles. Early sepsis is marked by inflammation and glycolysis, while late sepsis is marked by immune suppression and fatty acid oxidation. As an increasing body of data suggests, these metabolic and immune states may be interdependent.","abstract_html":"Sepsis is serious medical condition which kills millions of people worldwide each year. In the United States, severe sepsis has a mortality rate of 20-30%, with an annual cost of over $25 billion. Modern advances in supportive care have brought the mortality rate down to its current level, however there is currently no molecular-based treatment available for sepsis. Many treatments have been tested in clinical trials, but none have proven reliably beneficial. These treatments, however, seldom accounted for the fact sepsis has distinct stages with distinct immunometabolic profiles. Early sepsis is marked by inflammation and glycolysis, while late sepsis is marked by immune suppression and fatty acid oxidation. As an increasing body of data suggests, these metabolic and immune states may be interdependent.","abstract_has_math":false,"creators":["Millet, Patrick"],"institution":"Wake Forest University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015","date_published":"2015","updated_at":"2026-07-27T22:01:58Z","subjects":["Inflammation"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10339/57421","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Millet, Patrick"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2016-01-11T09:35:18Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2016-07-10T08:30:10Z"]},{"key":"dc:date.issued","label":"Date","values":["2015"]},{"key":"dc:publisher","label":"Institution","values":["Wake Forest University"]},{"key":"dc:type","label":"Dc Type","values":["Dissertation"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Inflammation"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10339/57421"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Sepsis is serious medical condition which kills millions of people worldwide each year. In the United States, severe sepsis has a mortality rate of 20-30%, with an annual cost of over $25 billion. Modern advances in supportive care have brought the mortality rate down to its current level, however there is currently no molecular-based treatment available for sepsis. Many treatments have been tested in clinical trials, but none have proven reliably beneficial. These treatments, however, seldom accounted for the fact sepsis has distinct stages with distinct immunometabolic profiles. Early sepsis is marked by inflammation and glycolysis, while late sepsis is marked by immune suppression and fatty acid oxidation. As an increasing body of data suggests, these metabolic and immune states may be interdependent."]},{"key":"dc:title","label":"Title","values":["INTERDEPENDENT REGULATION OF METABOLISM AND INFLAMMATION IN HUMAN MONOCYTES"]}]}],"canonical_facts":{"dc:creator":["Millet, Patrick"],"dc:date.accessioned":["2016-01-11T09:35:18Z"],"dc:date.available":["2016-07-10T08:30:10Z"],"dc:date.issued":["2015"],"dc:description.abstract":["Sepsis is serious medical condition which kills millions of people worldwide each year. In the United States, severe sepsis has a mortality rate of 20-30%, with an annual cost of over $25 billion. Modern advances in supportive care have brought the mortality rate down to its current level, however there is currently no molecular-based treatment available for sepsis. Many treatments have been tested in clinical trials, but none have proven reliably beneficial. These treatments, however, seldom accounted for the fact sepsis has distinct stages with distinct immunometabolic profiles. Early sepsis is marked by inflammation and glycolysis, while late sepsis is marked by immune suppression and fatty acid oxidation. As an increasing body of data suggests, these metabolic and immune states may be interdependent."],"dc:identifier.uri":["http://hdl.handle.net/10339/57421"],"dc:language.iso":["en"],"dc:publisher":["Wake Forest University"],"dc:subject":["Inflammation"],"dc:title":["INTERDEPENDENT REGULATION OF METABOLISM AND INFLAMMATION IN HUMAN MONOCYTES"],"dc:type":["Dissertation"]},"updated_at":"2026-07-27T22:01:58Z"}